October 5, 2017
At the halfway mark of 2017, here's a look at how these four gene therapy companies are performing so far...
February 21, 2017
Thom Calandra is known to investors in the resource space. Recently, he wrote about biotechnology and started his own index...
February 15, 2017
The US Patent Office has ruled “no interference in fact” on CRISPR-Cas9 Patent dispute.
November 3, 2016
The US, China and the UK are the top regions for genetics research.
March 10, 2016
Editas Medicine's share price went on a tear following its IPO in February. In the last two days, however, it's...